Treatment in Madrid (Spain)

Experience

On his return from London, he organized and directed the Arrhythmia Unit of the Cardiology Service of the Nuestra Señora del Pino University Hospital in Las Palmas until the year 2000.

Later he was associate head of the Arrhythmia Unit and Director of the Electrophysiology Laboratory of the Fundación Jiménez Díaz in Madrid.

Professor of Cardiology at the Autonomous University and Fellowship Program Director of the North American Society of Pacing and Electrophysiology (Heart Rhythm Society) positions that he held for 6 years until his transfer to the Quirónsalud Madrid University Hospital in 2006.

Dr. Cabrera has been the head of the Cardiology service at the Quirónsalud Madrid University Hospital since the hospital began operating in 2006.

Since January 2013, he is also head of the Cardiology Unit of the Ruber Juan Bravo Hospital Complex and in 2022 head of service of the new Olympia center.

He is a professor at the European University of Madrid where he directs the Chair of Clinical and Basic Translational Cardiology.

Title

Doctorate in Medicine and Surgery at the Faculty of Medicine of the University of Granada. He completed his post-graduate training as an interventional cardiologist in the Arrhythmia Unit (cardiac Electrophysiology laboratory) of the Fundación Jiménez Díaz in Madrid since 1994 -1996.

Senior Research Fellow. at the National Heart & Lung Institute. Royal Brompton. Paediatric Cardiac Morphology under the direction of Prf. Robert H Anderson in London (UK) during the year 1997.

Experience

• -Head of the Department of Functional Neurosurgery and Radiosurgery at Ruber International Hospital since 2005 .
• - Neurosurgeon in the Radiosurgery Department of Ruber International Hospital since 1993 .
• -Work experience at Puerta de Hierro Clinic, Madrid (1985–1989) .

Scientific and teaching activities

• -180 publications in national and international medical journals.
• 60 articles in leading international journals with high impact factor.
• - Participation in 230 scientific conferences as a speaker, including 100 invited presentations at international symposia.
• -Author : 3 published books and 22 chapters in scientific papers.
• - Honorary Professor of the Faculty of Medicine of the Autonomous University of Madrid .

Internships in international centers

• - La Timone Hospital, Marseille (France) – 2000, 2010, 2015.
• -Karolinska Hospital, Stockholm (Sweden) – 1993, 1996.
• - Birmingham Hospital, UK – 1987

Membership in scientific societies

• - Member of the International Society of Stereotactic Radiosurgery (ISRS) , is a member of the Executive Council and the Educational Committee .
• - Member of the Congress of Neurological Surgeons of the United States and the American Association of Neurological Surgeons .
• -Member of the Royal Academy of Medicine of Asturias, Spain .

Languages of practice

• -Spanish
• -English
• -French

Pathologies

-Benign brain tumors: meningiomas and neuromas:

-Cerebral vascular malformations:

-Obsessive-compulsive disorder treatment operations:

-Operations to combat nervous anorexia:

Publications

2023 | Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma in patients ≥ 65 years: a multi-institutional retrospective study Acta Neurochirurgica 165: 211–220,

2022 | Stereotactic radiosurgery for Kues grade IV vestibular schwannoma in young patients: a multi-institutional study Journal of Neuro-Oncology 160: 201–208.

2022 | Stereotactic radiosurgery versus active surveillance for asymptomatic, parafalcine, and parasagittal meningiomas: a matched cohort analysis from the IMPASSE Neurosurgery 90:750–757

2022| Active surveillance versus stereotactic radiosurgery for the treatment of patients with incident frontobasal meningioma - A subanalysis of the IMPASSE Cancers (Basel) trial. Mar 3;14(5):1300.

2022| Gamma Knife Outcomes and Recommendations and Complications: Patai fond Kuala Lumpur

2022| Radiosurgery for Mental Disorders LGKA Marsella

2022| The Role of SRS in Anorexia Nervosa ISRS Milan

2022| Expanding the indications for gamma knife radiosurgery Neuroonc and Rs Symp Malasia

2022 | Pituitary Adenoma: Conservative in Surgical Abortion Simp CUF Lisbo

Awards and certificates

2019|National Medical Prize XXI in the field of neurosurgery.

2018 | Editorial Board Member, American Journal of Psychiatry and Neurology

2015 | Factory Award torn away from the International Society of Stereotactic and Radiosurgery

2012 | Correspondent of the Real Medical Academy of Asturias.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous Sy at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation sys, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation sys and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Dr. Jaime Pérez de Oteyza is a Spanish hematologist and heads the Hematology and Hematology Oncology Department at HM Hospitales Group. He is an expert in diagnostics and treatment of hematology conditions and hematopoietic transplant, and has taken part in the first in Spain. He holds a degree in general medicine from CEU San Pablo University, has trained in lymphomas pathology at Kiel University, and has a specialty in hematology and hemotherapy from the University of Alcalá. He has won numerous awards for his scientific research and has published over 40 papers on his studies. He is a member of the Spanish Hematology and Hemotherapy Society.

Head of the Department of Neurosurgery in the HM Hospitales Clinic